RAISE Health – From Algorithms to Action

Artificial intelligence (AI) is revolutionizing how we develop, personalize, and deliver medical therapies. As AI becomes increasingly integral to drug discovery and clinical strategy, questions of ethics, equity, and transparency have never been more urgent. Stanford University’s RAISE Health initiative offers a model for guiding AI’s safe and responsible use across biomedical research, education, and care. This vision complements GMDP Academy’s focus in Module 8: Digital Technology in Medicines Development, where learners explore the intersection of technology and ethics in pharmaceutical innovation.

A Framework for Ethical AI in Health

RAISE Health was launched by Stanford Medicine and the Stanford Institute for Human-Centered Artificial Intelligence (HAI) with three foundational pillars: responsibility, safety, and equity (Armitage, 2025). In 2025, five seed grants were awarded to projects exemplifying these values, including:

  • CuraBench, which generates synthetic datasets to rigorously evaluate AI models.
  • Raising Health for IMPACT, a modular curriculum empowering clinicians to use AI responsibly.

These projects embody the kind of ethics-informed digital literacy GMDP Academy prioritizes. As Eric Topol emphasized in Deep Medicine, “Eventually, doctors will adopt AI and algorithms as their work partners”—a sentiment equally applicable to medicines development professionals (Topol, 2019).

Bridging Innovation and Impact: Beyond the Framework

While RAISE Health lays a vital ethical foundation for AI in healthcare, the broader pharmaceutical landscape is actively translating these principles into practice. Around the globe, new platforms and partnerships are emerging to accelerate drug discovery, enhance patient stratification, and streamline regulatory science—all powered by AI. These innovations don’t just reflect technical progress—they underscore the need for frameworks like RAISE Health to guide their responsible use. What follows is a look at how AI is reshaping the medicines development lifecycle, from molecular modeling to patient matching.

AI-Driven Drug Discovery: A Paradigm Shift

Globally, AI is transforming the drug development pipeline at unprecedented speed. Companies like Exscientia are reducing the guesswork of trial-and-error prescribing by matching patients with optimized treatments using machine learning and robotic automation. In one striking example, an Austrian patient achieved remission after receiving an AI-identified drug—following six failed chemotherapy rounds (Simonite, 2023).

Meanwhile, firms such as Generate Biomedicines and Absci are designing novel therapeutic proteins using generative AI models. These tools replicate the mechanisms behind text-to-image models like DALL-E, but instead of producing pictures, they create 3D-folded proteins with disease-specific functions.

Importantly, AI is not just speeding up experiments—it’s reshaping early-phase discovery. “It’s made a real difference,” said Jim Weatherall, VP of Data Science at AstraZeneca, describing how natural-language processing uncovered promising drug targets that traditional methods missed (Simonite, 2023).

Scaling AI Responsibly: From Molecules to Markets

According to the AI Index Report 2025, AI training efficiency has increased dramatically. Model training costs have dropped over 280-fold since 2022, and computational scale now doubles every five months—democratizing access to high-impact AI systems (Stanford HAI, 2025). But while AI can simulate chemical interactions and predict biological pathways, “the ultimate validation still needs to be done in the lab,” cautioned Luisa Salter-Cid, CSO at Pioneering Medicines (Simonite, 2023).

This speaks to one of GMDP Academy’s core values: digital innovation must complement—not replace—robust scientific and regulatory processes. Module 8 ensures learners understand how AI integrates into trial design, pharmacovigilance, and real-world evidence frameworks.

Ethics, Education, and Empowerment

The AI revolution in medicine also raises profound ethical and workforce challenges. Bill Gates recently noted that AI could help alleviate global physician shortages by offering clinical decision support and reducing burnout (Harrison, 2025). Yet these benefits are only achievable if professionals are equipped to understand the technologies they use.

This is why education is central to both RAISE Health and GMDP Academy’s mission. Through Module 8, learners engage with the ethical, legal, and practical dimensions of digital technologies, preparing them to lead responsibly in an AI-powered healthcare future.

Conclusion: Leading Responsibly in a Digital Era

AI’s role in medicines development is expanding rapidly—but without ethical guidance, its power could exacerbate disparities or erode trust. The RAISE Health initiative provides a critical example of what it means to lead responsibly. For GMDP Academy learners, especially those in Module 8, the challenge is not only to master emerging tools, but to shape how they’re applied—with precision, insight, and integrity.

References

Armitage, H. (2025, March 18). RAISE Health inaugural seed grant recipients announced. Stanford Medicine News Center. https://med.stanford.edu/news/all-news/2025/03/raise-health-grantees.html

Harrison, O. (2025, April 16). Bill Gates says AI is coming for 2 kinds of jobs that once seemed tech-proof. Business Insider. https://www.businessinsider.com/bill-gates-ai-job-shortages-doctors-teachers-work-free-time-2025-4

Pengelly, M. (2025, April 9). Dr Oz tells federal health workers AI could replace frontline doctors. The Guardian. https://www.theguardian.com/us-news/2025/apr/09/mehmet-oz-doctors-ai

RAISE Health. (2025). Seed grants: Advancing responsible AI in medicine. Stanford Medicine. https://med.stanford.edu/raisehealth/seedgrants.html

Simonite, T. (2023, February 15). AI is dreaming up drugs that no one has ever seen. Now we’ve got to see if they work. MIT Technology Review. https://www.technologyreview.com/2023/02/15/1067904/ai-automation-drug-development/

Stanford Institute for Human-Centered Artificial Intelligence. (2025). Artificial Intelligence Index Report 2025: Chapter 1 – Research and Development. https://hai-production.s3.amazonaws.com/files/hai_ai-index-report-2025_chapter1_final.pdf

Topol, E. J. (2019). Deep medicine: How artificial intelligence can make healthcare human again. Basic Books.

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred